FDA Approves Drug for Rare Autism-Linked Disorder

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that the drug showed great promise for people with autism. The agency said it…[#item_full_content]

Thune Rejects Filibuster Change as Trump Pushes SAVE America Act Vote

Senate Majority Leader John Thune is pushing back against calls to rewrite Senate rules to pass President Donald Trump’s top election reform priority, setting up a clash within the Republican Party over how to advance legislation requiring voter ID and proof of citizenship.[#item_full_content]

Poll: Voters Uneasy on AI, Distrust Both Parties

Voters across the country are uneasy about artificial intelligence, with a new NBC News poll showing most believe the risks of AI outweigh the benefits — and few trust either political party to manage it well.

Hegseth Vows ‘Most Intense Day’ of Iran Strikes

War Secretary Pete Hegseth said Tuesday that the United States was preparing for what he described as the “most intense day of strikes” yet in the ongoing military campaign against Iran.[#item_full_content]

Ruddy: Trump Won the War and Soon the Peace

The world has witnessed the near-total destruction of Iran’s military infrastructure and the dismantling of its nuclear ambitions. Iran’s naval power, missile systems, communications networks, and much of its air-defense have been devastated.[#item_full_content]

Senate Bill Forces Investors to Sell Rental Homes in 7 Years

A new provision in the Senate’s housing legislation would force large investors that build single-family rental homes to sell those properties within seven years — a move lawmakers say could help make homeownership more accessible but that industry groups warn could disrupt…[#item_full_content]

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.